SEC Company Response from Twist Bioscience Corp (TWST) (CIK 0001581280) (TWST) — Oct 26, 2018
Twist Bioscience Corp (TWST) (CIK 0001581280)
Date: Oct. 26, 2018 · CIK: 0001581280 · Accession: 0001193125-18-309378
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227672
Letter
Via EDGAR Submission Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, DC 20549-7010
Re: Twist Bioscience Corporation Amendment No. 2 to Registration Statement on Form S-1 Filed October 26, 2018 File No. 333-227672
Dear Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as the representatives of the several underwriters, hereby join in the request of Twist Bioscience Corporation (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 5:00 p.m. Eastern Time on October 30, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we, as the representatives of the several underwriters, wish to advise you that between October 17, 2018 through the date hereof we have distributed approximately 2,069 copies of the Company’s Preliminary Prospectus dated October 17, 2018 to prospective underwriters, dealers, institutional investors and others.
We, the undersigned, as the representative of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
(signature page follows)
Very truly yours,
J.P. MORGAN SECURITIES LLC
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
October 26, 2018
Via EDGAR Submission
Securities and Exchange
Commission
Division of Corporation Finance
100 F Street
N.E.
Washington, DC 20549-7010
Re:
Twist Bioscience Corporation
Amendment No. 2 to Registration Statement on Form S-1
Filed October 26, 2018
File No. 333-227672
Dear Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as the representatives of the several
underwriters, hereby join in the request of Twist Bioscience Corporation (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 5:00 p.m. Eastern Time on
October 30, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we, as the representatives of the
several underwriters, wish to advise you that between October 17, 2018 through the date hereof we have distributed approximately 2,069 copies of the Company’s Preliminary Prospectus dated October 17, 2018 to prospective underwriters,
dealers, institutional investors and others.
We, the undersigned, as the representative of the several underwriters, have complied and
will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
(signature page follows)
Very truly yours,
J.P. MORGAN SECURITIES LLC
COWEN
AND COMPANY, LLC
Acting severally on behalf of themselves and the several underwriters
J.P. MORGAN SECURITIES LLC
By:
/s/ Benjamin H. Burdett
Authorized Signatory
COWEN AND COMPANY, LLC
By:
/s/ E. James Streator, III
Authorized Signatory
(Signature Page to
Acceleration Request Letter)